<DOC>
	<DOCNO>NCT02783768</DOCNO>
	<brief_summary>Determination acute pulmonary toxicity e-cigarettes young adult major public health importance , e-cigarette vapor contains establish toxicant hypothesize cause acute damage airway pulmonary microvasculature may promote development CLD , remain effective therapy . The study therefore propose pilot study use randomize crossover design ten healthy young adult test acute effect standardize e-cigarette exposure two sensitive , safe , non-invasive imaging measure : ( 1 ) ventilation defect hyperpolarized helium-enhanced magnetic resonance imaging , ( 2 ) pulmonary microvascular blood flow gadolinium-enhanced pulmonary magnetic resonance angiography .</brief_summary>
	<brief_title>Ventilation Pulmonary Endothelium Toxicities E-cigarettes : A Randomized Crossover Pilot Study</brief_title>
	<detailed_description>Magnetic resonance imaging ( MRI ) angiography ( MRA ) measure promising approach detect characterize anticipate acute pulmonary toxicity e-cigarettes . Hyperpolarized helium ( 3He ) -enhanced MRI may sensitive spirometry , global lung function measure , determination airway toxicity . 3He-enhanced MRI use demonstrate extent ventilation defect healthy person normal spirometry ; measure ventilation change asthmatics pre- post-challenge bronchodilator methacholine ; predict pulmonary hospitalization person COPD . Meanwhile , recently , non-invasive measure pulmonary vascular toxicity lack . The investigator develop innovative measure pulmonary microvascular blood flow gadolinium ( Gd ) -enhanced MRA , investigator find markedly abnormal early chronic obstructive pulmonary disease ( COPD ) emphysema , associate increase endothelial microparticles , marker endothelial dysfunction . Nonetheless , neither sensitive , non-invasive , repeatable , reproducible measure ever use assess e-cigarette toxicity . It hypothesize e-cigarette vapor inhalation result acute increase global regional ventilation defect acute decrease global regional pulmonary microvascular perfusion . This pilot work provide experience data support subsequent funding application power definitively establish acute toxicity e-cigarette vapor various composition ( e.g. , without nicotine , without flavor ) person without chronic lung disease ( e.g. , asthma ) pulmonary ventilation microvascular perfusion . Furthermore , confirmation hypothesis sample would provide important preliminary evidence e-cigarette pulmonary toxicity inform interim regulatory decision , well potentially generate vivid image e-cigarette harm may meaningful general public therefore suitable use public education campaign .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>current use ecigarettes ( &gt; 1x/month &lt; 4 days/week ) chronic medical major psychiatric problem include current asthma selfreported heavy snoring/sleep apnea prebronchodilator FEV1 FVC &lt; 80 % predict FEV1/FVC &lt; low limit normal MRI exclusion ( pregnancy , claustrophobia , metal body , gadolinium allergy , eGFR &lt; 60 mL/min/1.73m2 ) MRI scan contrast within last 12 month plan MRI contrast next 6 month history &gt; 100 lifetime conventional cigarette use follow prior 30 day : conventional cigarette , marijuana &gt; 10 day , illicit drug , medication inhaler ( exclude hormonal contraceptive ) binge drinking ( â‰¥5 alcoholic beverages 2 hour ) prior two week adverse symptomatic response study ecigarette exposure ( e.g. , palpitation , shortness breath , chest pain , headache , dizziness )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>E-cigarettes</keyword>
	<keyword>COPD</keyword>
</DOC>